title: Short and long-term outcomes of endoscopic balloon dilatation for Crohn's disease strictures.
abstract: OBJECTIVE
  To investigate the short and long-term outcomes of endoscopic balloon dilatation (EBD) for Crohn's disease (CD) strictures.
  
  
  METHODS
  Between January 1995 and December 2011, 47 EBD procedures were performed in 30 patients (8 females and 22 males) with CD. All patients had strictures through which an endoscope could not pass, and symptoms of these strictures included abdominal pain, abdominal fullness, nausea, and/or vomiting. The 47 strictures included 17 anastomotic and 30 de novo strictures. Endoscopy and dilatation were performed under conscious sedation with intravenous diazepam or flunitrazepam. The dilatations were all performed using through-the-scope balloons with diameters from 8 mm to 20 mm on inflation and lengths of 30-80 mm. Each dilatation session consisted of two to four, 3-min multistep inflations of the balloon, repeated at intervals of 1 wk until adequate dilatation (up to 15-20 mm in diameter) was achieved. The follow-up data were collected from medical records and analyzed retrospectively. Primary success was defined as passage of the scope through the stricture after EBD. Long-term outcomes were analyzed focusing on intervention-free survival and surgery-free survival demonstrated by the Kaplan-Meier method. (Intervention-free meant cases in which neither endoscopic balloon re-dilatation nor surgery was needed after the first dilatation during the observation period). The log rank test was used to evaluate the difference in long-term outcomes between anastomotic and de novo stricture cases.
  
  
  RESULTS
  Primary success was achieved in 44 of the 47 strictures (93.6%). Balloon dilatations failed in 3 cases (6.4%). In 1 case, EBD was a technical failure because the guide-wire could not be passed through the stricture which showed severe adhesion and was a flexural lesion of the intestine. In 2 cases, unexpected perforations occurred immediately after balloon dilatation. Of the 47 treatments, complications occurred in 5 (10.6%). All 5 patients had de novo strictures. One suffered bleeding, two high fever and there were colorectal perforations. One of the patients with a colorectal perforation was treated surgically, the other was managed conservatively. These 2 cases correspond to the two aforementioned EBD failures. Long-term outcomes were evaluated for the 44 successfully-treated strictures after a median follow-up of 26 mo (range, 2-172 mo). During the observation period, re-strictures after EBDs occurred in 26 cases (60.5%). Fourteen of these 26 re-stricture cases underwent EBD again, but in two EBD failed and surgery was ultimately performed in both cases. Twelve of the 26 re-stricture cases were initially treated surgically when the re-strictures occurred. Finally, 30 of the 47 strictures (63.8%) were successfully managed with EBD, allowing surgery to be avoided. Intervention-free survival evaluated by the Kaplan-Meier method was 75% at 12 mo, 58% at 24 mo, and 43% at 36 mo. There was no significant difference between the anastomotic strictures (n = 16) and de novo strictures (n = 28) in the intervention-free survival as evaluated by the log-rank test. Surgery-free survival evaluated by the Kaplan-Meier method was 90% at 12 mo, 75% at 24 mo, and 53% at 36 mo. The 16 anastomotic strictures were associated with significantly better surgery-free survivals than the 28 de novo strictures (log-rank test: P < 0.05).
  
  
  CONCLUSIONS
  Anastomotic strictures were associated with better long-term outcomes than de novo strictures, indicating that stricture type might be useful for predicting the long-term outcomes of EBD.
authors: Division of Gastroenterology, Tohoku University Graduate School of Medicine, Sendai 980-8574, Japan. kendo@med.tohoku.ac.jp
authors: Katsuya
authors: K
authors: Endo
authors: Seiichi
authors: S
authors: Takahashi
authors: Hisashi
authors: H
authors: Shiga
authors: Yoichi
authors: Y
authors: Kakuta
authors: Yoshitaka
authors: Y
authors: Kinouchi
authors: Tooru
authors: T
authors: Shimosegawa
mesh_terms: D000759:Adjuvants, Anesthesia / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D000368:Aged; D000714:Anastomosis, Surgical; D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D003251:Constriction, Pathologic / Q000628:therapy*; D003424:Crohn Disease / Q000628:therapy*; D003975:Diazepam / Q000627:therapeutic use; D004106:Dilatation / Q000009:adverse effects; D018572:Disease-Free Survival; D004724:Endoscopy / Q000379:methods*; D005260:Female; D005445:Flunitrazepam / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D012189:Retrospective Studies; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D000759:Adjuvants, Anesthesia; D014151:Anti-Anxiety Agents; D005445:Flunitrazepam; D003975:Diazepam
keywords: Anastomotic; Crohn’s disease; De novo; Endoscopic balloon dilatation; Outcome; Stricture